BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25525184)

  • 21. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan.
    Aurangabadkar H; Ali Z
    Clin Nucl Med; 2013 Dec; 38(12):e471-3. PubMed ID: 23603603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2.
    Li F; Jørgensen JT; Forman J; Hansen AE; Kjaer A
    J Nucl Med; 2016 Mar; 57(3):437-43. PubMed ID: 26585061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.
    Green MA; Mathias CJ; Welch MJ; McGuire AH; Perry D; Fernandez-Rubio F; Perlmutter JS; Raichle ME; Bergmann SR
    J Nucl Med; 1990 Dec; 31(12):1989-96. PubMed ID: 2266398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular myocardium metastasis in a patient with primary renal cell carcinoma detected by 18F-FDG PET/CT.
    Pinnamaneni N; Muthukrishnan A
    Clin Nucl Med; 2012 Jul; 37(7):e181-3. PubMed ID: 22691531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.
    Wong TZ; Lacy JL; Petry NA; Hawk TC; Sporn TA; Dewhirst MW; Vlahovic G
    AJR Am J Roentgenol; 2008 Feb; 190(2):427-32. PubMed ID: 18212229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary study of whole-body diffusion-weighted imaging in detecting pulmonary metastatic lesions from clear cell renal cell carcinoma: comparison with CT.
    Liu J; Yang X; Li F; Wang X; Jiang X
    Acta Radiol; 2011 Nov; 52(9):954-63. PubMed ID: 21903870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
    Zhang T; Das SK; Fels DR; Hansen KS; Wong TZ; Dewhirst MW; Vlahovic G
    AJR Am J Roentgenol; 2013 Nov; 201(5):W698-706. PubMed ID: 24147499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Positron Emission Tomography Quantification Using Magnetic Resonance- and Computed Tomography-Based Attenuation Correction in Physiological Tissues and Lesions: A Whole-Body Positron Emission Tomography/Magnetic Resonance Study in 66 Patients.
    Seith F; Gatidis S; Schmidt H; Bezrukov I; la Fougère C; Nikolaou K; Pfannenberg C; Schwenzer N
    Invest Radiol; 2016 Jan; 51(1):66-71. PubMed ID: 26348596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs.
    Tarkia M; Saraste A; Saanijoki T; Oikonen V; Vähäsilta T; Strandberg M; Stark C; Tolvanen T; Teräs M; Savunen T; Green MA; Knuuti J; Roivainen A
    Nucl Med Biol; 2012 Jul; 39(5):715-23. PubMed ID: 22264857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CT-perfusion versus [(15)O]H2O PET in lung tumors: effects of CT-perfusion methodology.
    Kramer GM; Yaqub M; Bahce I; Smit EF; Lubberink M; Hoekstra OS; Boellaard R
    Med Phys; 2013 May; 40(5):052502. PubMed ID: 23635292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM.
    Haynes NG; Lacy JL; Nayak N; Martin CS; Dai D; Mathias CJ; Green MA
    J Nucl Med; 2000 Feb; 41(2):309-14. PubMed ID: 10688116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose quantitative myocardial blood flow imaging using 15O-water and PET without attenuation correction.
    Lubberink M; Harms HJ; Halbmeijer R; de Haan S; Knaapen P; Lammertsma AA
    J Nucl Med; 2010 Apr; 51(4):575-80. PubMed ID: 20237035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases.
    Flower MA; Zweit J; Hall AD; Burke D; Davies MM; Dworkin MJ; Young HE; Mundy J; Ott RJ; McCready VR; Carnochan P; Allen-Mersh TG
    Eur J Nucl Med; 2001 Jan; 28(1):99-103. PubMed ID: 11202458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of 62Zn/62Cu positron generator: perfusion and plasma pool images in normal subjects.
    Okazawa H; Fujibayashi Y; Yonekura Y; Tamaki N; Nishizawa S; Magata Y; Ishizu K; Tsuchida T; Sadato N; Konishi J
    Ann Nucl Med; 1995 May; 9(2):81-7. PubMed ID: 7662494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
    Turkbey B; Lindenberg ML; Adler S; Kurdziel KA; McKinney YL; Weaver J; Vocke CD; Anver M; Bratslavsky G; Eclarinal P; Kwarteng G; Lin FI; Yaqub-Ogun N; Merino MJ; Linehan WM; Choyke PL; Metwalli AR
    Abdom Radiol (NY); 2016 Jan; 41(1):109-18. PubMed ID: 26830617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.
    Akay S; Kocaoglu M; Emer O; Battal B; Arslan N
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma. A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose.
    Apostolova I; Hofheinz F; Buchert R; Steffen IG; Michel R; Rosner C; Prasad V; Köhler C; Derlin T; Brenner W; Marnitz S
    Strahlenther Onkol; 2014 Jun; 190(6):575-81. PubMed ID: 24535649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial human experience with Rubidium-82 renal PET/CT imaging.
    Tahari AK; Bravo PE; Rahmim A; Bengel FM; Szabo Z
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):25-31. PubMed ID: 24529052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.